Radnor Capital Management, LLC Johnson & Johnson Transaction History

Radnor Capital Management, LLC

$328 Million
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$155.22 - $162.74 $470,627 - $493,427	-3,032 Reduced 5.56%	51,504 $8.15 Million
Q4 2023 Jan 11, 2024	BUY	$145.6 - $158.88 $612,976 - $668,884	4,210 Added 8.37%	54,536 $8.55 Million
Q3 2023 Oct 12, 2023	BUY	$155.75 - $174.48 $7.84 Million - $8.78 Million	50,326 New	50,326 $7.84 Million
Q1 2023 Apr 06, 2023	BUY	$151.05 - $180.26 $622,779 - $743,211	4,123 Added 12.47%	37,194 $5.77 Million
Q4 2022 Jan 09, 2023	BUY	$160.2 - $179.79 $16,019 - $17,979	100 Added 0.3%	33,071 $5.93 Million
Q3 2022 Oct 12, 2022	SELL	$161.33 - $179.52 $25,974 - $28,902	-161 Reduced 0.49%	32,971 $5.39 Million
Q2 2022 Jul 11, 2022	SELL	$168.19 - $186.01 $196,950 - $217,817	-1,171 Reduced 3.41%	33,132 $5.88 Million
Q1 2022 Apr 25, 2022	SELL	$158.14 - $179.59 $177,116 - $201,140	-1,120 Reduced 3.16%	34,303 $6.08 Million
Q4 2021 Jan 20, 2022	BUY	$155.93 - $173.01 $5.52 Million - $6.13 Million	35,423 New	35,423 $6.06 Million
Q3 2021 Oct 26, 2021	SELL	$161.5 - $179.47 $5.73 Million - $6.37 Million	-35,488 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$159.48 - $171.07 $23,762 - $25,489	-149 Reduced 0.42%	35,488 $5.85 Million
Q1 2021 Apr 26, 2021	SELL	$153.07 - $170.48 $97,658 - $108,766	-638 Reduced 1.76%	35,637 $5.86 Million
Q4 2020 Jan 13, 2021	BUY	$137.11 - $157.38 $88,435 - $101,510	645 Added 1.81%	36,275 $5.71 Million
Q3 2020 Nov 02, 2020	BUY	$140.38 - $153.83 $270,793 - $296,738	1,929 Added 5.72%	35,630 $5.31 Million
Q2 2020 Jul 28, 2020	BUY	$128.81 - $155.51 $119,793 - $144,624	930 Added 2.84%	33,701 $4.73 Million
Q1 2020 Apr 07, 2020	SELL	$111.14 - $153.99 $140,147 - $194,181	-1,261 Reduced 3.71%	32,771 $4.3 Million
Q4 2019 Jan 10, 2020	SELL	$127.5 - $146.44 $38,632 - $44,371	-303 Reduced 0.88%	34,032 $4.96 Million
Q3 2019 Oct 07, 2019	SELL	$126.95 - $142.14 $19,042 - $21,320	-150 Reduced 0.43%	34,335 $4.44 Million
Q2 2019 Jul 18, 2019	BUY	$131.15 - $144.24 $223,348 - $245,640	1,703 Added 5.19%	34,485 $4.8 Million
Q1 2019 Apr 25, 2019	SELL	$125.72 - $139.79 $40,859 - $45,431	-325 Reduced 0.98%	32,782 $4.58 Million
Q4 2018 Jan 16, 2019	BUY	$122.84 - $147.84 $82,548 - $99,348	672 Added 2.07%	33,107 $4.27 Million
Q3 2018 Oct 04, 2018	SELL	$121.58 - $142.88 $1,945 - $2,286	-16 Reduced 0.05%	32,435 $4.48 Million
Q1 2018 Apr 20, 2018	SELL	$125.1 - $148.14 $225,430 - $266,948	-1,802 Reduced 5.26%	32,451 $4.16 Million
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $62,985 - $68,937	-480 Reduced 1.38%	34,253 $4.79 Million
Q2 2017 Aug 09, 2017	BUY	N/A	34,733	34,733 $4.6 Million

Others Institutions Holding JNJ

# of Institutions

4,162

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $424B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.

Account